MAP3K4 Polyclonal Antibody, AbBy Fluor-350 Conjugated, BF350, Rabbit

Catalog Number: BSS-BS-11883R-BF350
Article Name: MAP3K4 Polyclonal Antibody, AbBy Fluor-350 Conjugated, BF350, Rabbit
Biozol Catalog Number: BSS-BS-11883R-BF350
Supplier Catalog Number: bs-11883R-BF350
Alternative Catalog Number: BSS-BS-11883R-BF350-100
Manufacturer: Bioss
Host: Rabbit
Category: Antikörper
Application: IF
Conjugation: BF350
Alternative Names: FLJ42439, KIAA0213, M3K4_HUMAN, MAP three kinase 1, MAP3K4, MAPK/ERK kinase kinase 4, MAPKKK4 antibodyMEK kinase 4, MEKK 4, MEKK4, Mitogen-activated protein kinase kinase kinase 4, MTK1, PRO0412, RP3-473J16.4
Mitogen-activated protein (MAP) kinase cascades are activated by various extracellular stimuli including growth factors. The MEK kinases (also designated MAP kinase kinase kinases, MKKKs, MAP3Ks or MEKKs) phosphorylate and thereby activate the MEKs (also called MAP kinase kinases or MKKs), including ERK, JNK and p38. These activated MEKs in turn phosphorylate and activate the MAP kinases. The MEK kinases include Raf-1, Raf-B, Mos, MEK kinase-1, MEK kinase-2, MEK kinase-3, MEK kinase-4, ASK 1 (MEK kinase-5) and MAP3K6 (MEK kinase-6). MEK kinase-1 has been shown to phosphorylate MEK-1 via Raf-independent pathway. Evidence suggests that MEK-3 is preferentially activated by MEK kinase-3 and that MEK-4 is activated by both MEK kinase-2 and MEK kinase-3. MEK kinase-4 has been shown to specifically activate the JNK path-way. ASK1 activates both MEK-4 and MEK-3/MEK-6 pathways.
Clonality: Polyclonal
Concentration: 1ug/ul
Buffer: Aqueous buffered solution containing 0.01M TBS (pH7.4) with 1% BSA, 0.02% Proclin300 and 50% Glycerol.
Source: KLH conjugated synthetic peptide derived from human MAP3K4/MEK kinase-4
Target: MAP3K4
Application Dilute: IF(IHC-P)(1:50-200), IF(IHC-F)(1:50-200), IF(ICC)(1:50-200)